American Medical Systems Holdings Inc. is engaged in developing and delivering solutions to physicians treating men’s and women’s pelvic health conditions. Its product portfolio includes products for erectile restoration and men’s incontinence, as well as products and therapies targeted at benign prostatic hyperplasia (BPH) in men, as well as urinary incontinence, pelvic organ prolapse and menorrhagia in women. The Company’s primary physician customers include urologists, gynecologists, urogynecologists and colorectal surgeons. During the fiscal year ended January 3, 2009 (fiscal 2008), men’s health contributed 44% of total net sales, BPH therapy contributed 23%and women’s health contributed 33% of the Company’s total revenues.